Cirrhosis Support Group
Cirrhosis is a consequence of chronic liver disease, most commonly caused by alcoholism and hepatitis C. Ascites is the most common complication of cirrhosis and is associated with a poor quality of life, increased risk of infections, and a poor long term outcome. Liver damage from cirrhosis cannot be reversed, but treatment can stop or delay further progression and...
I can understand the impulse to take these drugs,
but obvoulsy you cannot be on them for life and it seems
just a short term loss
The problem is, its so easy to put any weight loss back on again in half the time it took to lose it.
popular diet drug 'can potentially cause serious liver damage'
A popular diet drug can potentially cause serious liver damage, regulators have warned.
By Kate Devlin, Medical Correspondent
Published: 7:30AM BST 28 May 2010
Although they described the problem as rare, they warned dieters to look out for symptoms which can include itching, yellow eyes or skin, or a loss of appetite.
The regulators had previously launched an investigation into Alli, the over-the counter diet drug made by GlaxoSmithKline (GSK), and Xenical, the prescription version of the medication.
The Food and Drug Administration (FDA) in America, which issued the warning, said that the move followed reports of 13 cases of severe liver damage in patients.
The organisation has now asked GSK to change the labelling of the drug in America to make consumers aware of the potential risk.
Alli first went on sale in Britain last April and is designed to help slimmers shift extra pounds.
It is supposed to be sold only to the overweight, although there has been evidence of chemists selling it to slim people.
The FDA estimates that 40 million people across the world have taken the drug.
A spokesman for Alli said that the ruling would make no difference to packaging in Britain, which already contains a warning about potential liver problems.
GSK has previously said that overweight and obese people are more prone to liver conditions.
Howard Marsh, chief medical officer for GSK, said: GSK is committed to ensuring that consumers and physicians understand the safety profile of orlistat and alli.
GSK wants people to have the information they need to choose the right weight loss aid for their situation.
In a statement the FDA said: At this time, a cause-and-effect relationship has not been established.
*
*
*
but obvoulsy you cannot be on them for life and it seems
just a short term loss
The problem is, its so easy to put any weight loss back on again in half the time it took to lose it.
popular diet drug 'can potentially cause serious liver damage'
A popular diet drug can potentially cause serious liver damage, regulators have warned.
By Kate Devlin, Medical Correspondent
Published: 7:30AM BST 28 May 2010
Although they described the problem as rare, they warned dieters to look out for symptoms which can include itching, yellow eyes or skin, or a loss of appetite.
The regulators had previously launched an investigation into Alli, the over-the counter diet drug made by GlaxoSmithKline (GSK), and Xenical, the prescription version of the medication.
The Food and Drug Administration (FDA) in America, which issued the warning, said that the move followed reports of 13 cases of severe liver damage in patients.
The organisation has now asked GSK to change the labelling of the drug in America to make consumers aware of the potential risk.
Alli first went on sale in Britain last April and is designed to help slimmers shift extra pounds.
It is supposed to be sold only to the overweight, although there has been evidence of chemists selling it to slim people.
The FDA estimates that 40 million people across the world have taken the drug.
A spokesman for Alli said that the ruling would make no difference to packaging in Britain, which already contains a warning about potential liver problems.
GSK has previously said that overweight and obese people are more prone to liver conditions.
Howard Marsh, chief medical officer for GSK, said: GSK is committed to ensuring that consumers and physicians understand the safety profile of orlistat and alli.
GSK wants people to have the information they need to choose the right weight loss aid for their situation.
In a statement the FDA said: At this time, a cause-and-effect relationship has not been established.
*
*
*
The difficult part is keep it off. Constantly being vigilany about diet is just one of the pains of being diabetic.
One of the common consequences of liver disease is a malfunctioning pancrease and problems with insulin resistance
hence diabetes.
There are many diabtic people out there unaware of the condition.
If caught early you can slow down its progress.
Lots of people want to bury their heads and I can understand that
unfortunatly it does not just go away so from my point of view I would rather know. Yea or Nay!